Results 41 to 50 of about 1,747,294 (351)

Psychosocial Need Analysis of Patients with Pulmonary Tuberculosis. [PDF]

open access: yes, 2014
Pulmonary tuberculosis (TB) is a chronic pulmonary disease impacted on physical and psychosocial of the patients. However, to date, the goverment’s programs has not address the psychososial problem of the patients yet.
Hernawati, T. (Taty)   +3 more
core   +2 more sources

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

open access: yesPLoS ONE, 2013
Rationale New approaches to define factors underlying the immunopathogenesis of pulmonary diseases including sarcoidosis and tuberculosis are needed to develop new treatments and biomarkers. Comparing the blood transcriptional response of tuberculosis to
C. Bloom   +27 more
semanticscholar   +1 more source

Malignant Pleural Mesothelioma Treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi“ in Ten-Year Period (from 1998 to 2007)

open access: yesBiomolecules & Biomedicine, 2008
Malignant pleural mesothelioma (MPM) is the most common primary malign tumour of pleura. The aim of this study was to evaluate cases of MPM diagnosed and treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi” during ten-year period (1998-
Vesna Čukić   +5 more
doaj   +1 more source

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India [PDF]

open access: yes, 2015
Background Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in high-burden settings. This study assessed the impact of up-front Xpert MTB/RIF testing on detection of pulmonary tuberculosis (PTB)
Alavadi, U   +19 more
core   +1 more source

The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients

open access: yesFrontiers in Cellular and Infection Microbiology, 2019
Cross talk occurs between the human gut and the lung through a gut-lung axis involving the gut microbiota. However, the signatures of the human gut microbiota after active Mycobacterium tuberculosis infection have not been fully understood.
Yongfei Hu   +12 more
semanticscholar   +1 more source

Model of Empowerment to Improve Autonomy Directly Observed Treatment (DOT) Tuberculosis Patients [PDF]

open access: yes, 2016
Empowerment as not yet optimal health promotion efforts done to enhance the autonomy of Directly Observed Treatment (DOT), which affect the success of the recovery of patients with pulmonary tuberculosis.
Abdullah, E. (Endang)   +3 more
core   +2 more sources

PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population

open access: yesBMC Infectious Diseases, 2021
Background Rapid identification of pathogenic Mycobacterium species is critical for a successful treatment. However, traditional method is time-consuming and cannot discriminate isolated non-tuberculosis mycobacteria (NTM) at species level.
Qing Zhang, Heping Xiao, Liping Yan
doaj   +1 more source

Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits

open access: yesCell Communication and Signaling, 2013
BackgroundPulmonary infection of humans by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), results in active disease in 5-10% of individuals, while asymptomatic latent Mtb infection (LTBI) is established in the remainder.
S. Subbian   +11 more
semanticscholar   +1 more source

Efficacy of the Xpert Mycobacterium tuberculosis/rifampicin assay for diagnosing sputum-smear negative or sputum-scarce pulmonary tuberculosis in bronchoalveolar lavage fluid

open access: yesInternational Journal of Infectious Diseases, 2021
Objective: To evaluate he diagnostic performance of the Xpert Mycobacterium tuberculosis/Rifampin (MTB/RIF) assay in bronchoalveolar lavage fluid (BALF).
Juan Yang   +9 more
doaj   +1 more source

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control. [PDF]

open access: yes, 2014
BACKGROUND: Mass drug administration (MDA) with azithromycin, carried out for the control of blinding trachoma, has been linked to reduced mortality in children.
A Amza   +46 more
core   +2 more sources

Home - About - Disclaimer - Privacy